// App-Quantinova.ai

DOP064 : ECCO expert consensus and topical review on treatment exit strategies in inflammatory bowel disease

Researchers

Presenter

  • G Doherty

Principal Investigators

  • K Katsanos

  • J Burisch

  • M Allez

  • K Papamichael

  • A Stallmach

  • R Mao

  • I Prytz Berset

  • J Gisbert

  • S Sebastian

  • J Kierkus

  • L Lopetuso

  • E Szymanska

  • E Louis

Medical Centers

  • St. Vincent's University Hospital, Centre for Colorectal Disease, Dublin, Ireland

  • University and Medical School of Ioannina, Ioannina, Greece

  • Gastrounit, North Zealand University Hospital, Frederikssund, Denmark

  • Hôpital Saint-Louis, APHP, INSERM UMRS 1160, Université Denis Diderot, Paris, France

  • Beth Israel Deaconess Medical Center, Gastroenterology, Boston, USA

  • University Hospital Essen, Department of Medical Oncology, Essen, Germany.

  • Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China

  • alesund Hospital, Department of Gastroenterology, Alesund, Norway

  • Hospital Universitario de La Princesa, Gastroenterology, Madrid, Spain

  • Hull and East Yorkshire NHS Trust, Hull and York Medical School, Hull, UK

  • The Children's Memorial Health Institute, Department of Gastroenterology, Hepatology, Feeding Disorders and Pediatrics, Warsaw, Poland

  • Catholic University of Rome - A. Gemelli Hospital, Department of Internal Medicine and Gastroenterology, Rome, Italy

  • CHU Liège, Sart Tilman, Department of Gastroenterology, Liège, Belgium

Locations

  • Ireland

  • Greece

  • Denmark

  • France

  • United States

  • Germany

  • China

  • Norway

  • Spain

  • United Kingdom

  • Poland

  • Italy

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A